These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7123064)

  • 1. [Fulminant hepatitis in patients with mixed connective tissue disease under antitubercular treatment with hydrazide and rifampicin].
    Waitzberg VR; Gayotto LC
    Rev Hosp Clin Fac Med Sao Paulo; 1982 Feb; 37(1):48-51. PubMed ID: 7123064
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].
    Jean R; Bonnet H; Pages P; Dumas R; Greze J
    Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].
    Derveaux L; Demedts M; Fevery J; Gyselen A
    Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1008-12. PubMed ID: 7402377
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis].
    Volosevich GV
    Probl Tuberk; 1989; (9):72-3. PubMed ID: 2587561
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic hepatitis with isoniazid and rifampin. A meta-analysis.
    Steele MA; Burk RF; DesPrez RM
    Chest; 1991 Feb; 99(2):465-71. PubMed ID: 1824929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hydrazide-rifampicin: hepatotoxicity in children].
    Uriz Urzainqui S; Masvidal Aliberch RM; Sabriá Pau J; Bofill Bernaldo AM
    An Esp Pediatr; 1981 Oct; 15(4):401-3. PubMed ID: 7337305
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fatal liver cell necrosis following short-term administration of isoniazid and rifampicin to a patient already under treatment with antiepileptics].
    Lenders JW; Bartelink AK; van Herwaarden CL; van Haelst UJ; van Tongeren JH
    Ned Tijdschr Geneeskd; 1983 Mar; 127(10):420-3. PubMed ID: 6835412
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of acute hepatitis occurred during treatment with isoniazid and rifampicin (author's transl)].
    Kameda K; Kawabata S; Shirai S
    Kekkaku; 1980 May; 55(5):247-51. PubMed ID: 7412075
    [No Abstract]   [Full Text] [Related]  

  • 10. [Synergistic effect of rifampicin on hepatotoxicity of isoniazid].
    Skakun NP; Shman'ko VV
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):185-9. PubMed ID: 4015060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present views on isoniazid and isoniazid-rifampicin hepatitis.
    Pessayre D
    Agressologie; 1982 Jan; 23(A):13-5. PubMed ID: 7081577
    [No Abstract]   [Full Text] [Related]  

  • 12. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.
    Li F; Lu J; Cheng J; Wang L; Matsubara T; Csanaky IL; Klaassen CD; Gonzalez FJ; Ma X
    Nat Med; 2013 Apr; 19(4):418-20. PubMed ID: 23475203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of adverse reactions of chronic drug therapy as examplified with the hepatotoxic action of isoniazid and rifampicin].
    Bartmann K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1518-29. PubMed ID: 347784
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatal hepatitis after treatment with isoniazid and rifampicin in a patient on anticonvulsant therapy.
    Bartelink AK; Lenders JW; van Herwaarden CL; van Haelst UJ; van Tongeren JH
    Tubercle; 1983 Jun; 64(2):125-8. PubMed ID: 6612792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isoniazid-rifampicin: a model for hepatotoxicity and for bibliographic Anglomania].
    Toulet J; Viteau JM
    Gastroenterol Clin Biol; 1978; 2(8-9):756-7. PubMed ID: 361483
    [No Abstract]   [Full Text] [Related]  

  • 16. [Icterus caused by rifampicin and isoniazide].
    Haber I; Hubens H; Buyssens N
    Tijdschr Gastroenterol; 1974; 17(3):165-76. PubMed ID: 4454055
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
    Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
    Tubercle; 1971 Sep; 52(3):182-90. PubMed ID: 4255439
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hazards of antitubercular treatment--case report].
    Dudziak M; Sułek M
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):752-3. PubMed ID: 1488366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis and antitubercular therapy.
    Mahashur AA; Prabhudesai PP
    J Assoc Physicians India; 1991 Aug; 39(8):595-6. PubMed ID: 1814871
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxic hepatitis (liver and antitubercular drugs)].
    Kohan S
    Acta Gastroenterol Latinoam; 1977 Dec; 7(4):301-4. PubMed ID: 617560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.